Eledon pharmaceuticals to present at svb securities global biopharma conference

Irvine, calif., feb. 08, 2023 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today announced that david-alexandre c. gros, chief executive officer, will present at the upcoming svb securities global biopharma conference on february 15, 2023, at 5:00 p.m. et.
ELDN Ratings Summary
ELDN Quant Ranking